Concepedia

Shengmeng Di

SD

15

Publications

1.1K

Citations

14

H-Index

2008

Active since

Affiliations

Renji Hospital(Current)

State Key Laboratory of Oncogene and Related Genes

Shanghai Cancer Institute

Northwestern Polytechnical University

Shanghai Jiao Tong University

Shengmeng Di is an author at Renji Hospital specializing in medicine, engineering, and mechanobiology.

Top concepts

Publications per year

2008–2022

15

Publications

15

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Min Yu, Hong Luo, Mingliang Fan et al. · Molecular Therapy · 2017 · 177 citations · Full text

Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma

Xiuqi Wu, Hong Luo, Bizhi Shi et al. · Molecular Therapy · 2019 · 153 citations · Full text

Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

Ying Liu, Shengmeng Di, Bizhi Shi et al. · The Journal of Immunology · 2019 · 134 citations

Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice

Ruixin Sun, Hong Luo, Su Jingwen et al. · Molecular Therapy · 2020 · 115 citations · Full text

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells

Shengmeng Di, Min Zhou, Zeyan Pan et al. · Frontiers in Oncology · 2019 · 81 citations · Full text

Rows per page

1–5 of 15